LCM
Lynx1 Capital Management Portfolio holdings
AUM
$494M
1-Year Est. Return
143.06%
This Fund
S&P 500
1 Year Est. Return
+143.06%
AUM
$494M
AUM Growth
+$2.7M
(+0.55%)
Holding
27
Top Buys
| 1 | +$28.8M | |
| 2 | +$24.9M | |
| 3 | +$24.6M | |
| 4 |
Korro Bio
KRRO
|
+$15.8M |
| 5 |
Xencor
XNCR
|
+$10.5M |
Top Sells
| 1 | +$144M | |
| 2 | +$46.5M | |
| 3 | +$5.3M | |
| 4 |
iBio
IBIO
|
+$874K |
| 5 |
Allogene Therapeutics
ALLO
|
+$677K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRUS
26
DELISTED
Merus
MRUS
| – | – |
-1,534,141
|
|
||
27
Protagonist Therapeutics
PTGX
$6.2B
| – | – |
-700,014
|
|